Thanks to visit codestin.com Credit goes to www.ft.com
Takeover comes as industry’s biggest buyout groups collectively seek to deploy more than $2tn in unused cash
Danish drugmaker grapples with slowing growth and falling share price
Working group within European Chemicals Agency flags substance as toxic for humans
London-based CoMind is aiming to start selling its medical device in 2027
AI group tailoring its chatbot to integrate with biomedical databases and coding tools
Device improves vision of people suffering from advanced macular degeneration
AstraZeneca, Daiichi Sankyo and Gilead report promising trial results in ‘triple negative’ breast cancer
Antoine de Saint-Affrique says US push to counter obesity and additives align with French group’s own initiatives
Acquisition by private equity groups would be one of the biggest take-private deals of the year
NHS likely to pay billions more for some medicines in exchange for lower tariffs on British pharma exports
US administration in negotiations over cost of Danish group’s best-selling weight loss drug
Agreement would exempt Merck-owned group from US tariffs and let it list its fertility drugs on president’s future online site
Healthcare group faces lawsuit on behalf of 3,000 individuals after battling US litigation
The potential anti-ageing effects of molecule spermidine have attracted longevity researchers and the wellness industry
Watchdog finds regulatory system is ‘not fit for purpose’ but stops short of proposing structural reform of sector
Split of unit making knee and hip replacements comes as US healthcare group seeks shift to higher-growth areas
Clinical studies can be finished faster and cheaper than in US and provide an earlier sign of a drug’s potential
Failed hospital operator’s administrators seeking about £2bn damages from accounting firm in trial over missed ‘red flags’
The sector is still well off its peak and far behind its Chinese rivals
Levels of antimicrobial resistance highest in south-east Asia and eastern Mediterranean
Results are due soon from two studies using semaglutide to treat thousands of people with the disease
Study story: Viviane Joalland signed up for an EMBA to develop her leadership role in the French health sector
Luke Miels is known for commercial execution and successful bolt-on deals
Chief executive Pascal Soriot applauds the deal with Donald Trump as ‘a big win’ for US patients
Accelerating the technology’s safe adoption in hospitals should be a priority